Donor T cells lacking Fas ligand, and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients

被引:21
|
作者
Marks, L
Altman, NH
Podack, ER
Levy, RB
机构
[1] Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
[2] Univ Miami, Sch Med, Dept Pathol, Miami, FL 33101 USA
关键词
D O I
10.1097/01.TP.0000110416.96307.D5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Graft-versus-host disease (GvHD) is a frequent impediment to therapeutically successful allogeneic bone-marrow transplantation (BMT). This investigation further examines the roles of two potential donor cytotoxic effector mechanisms previously implicated in tissue pathogenesis. Cytotoxically double deficient (B6-cdd) T cells (lacking functional fas ligand and perforin) and wild-type (B6-wt) donor T-cell transplantation in a minor antigen-mismatched BMT model (C57BL/6 --> C3H.SW) resulted in similar mortality and weight loss. Histopathologic findings revealed mononuclear infiltrates and cellular atrophy in GvHD target tissues (liver, stomach) in recipients of B6-wt and B6-edd donor T cells. Both recipients also exhibited GvH-associated lymphohematopoietic compartment (LHC) alterations as evidenced by inverted CD4:CDS ratios and B-cell hypoplasia. Notably, transplants using recombinant inbred mHAg disparate recipients demonstrated that B6-cdd T cells induced lethal GvHD in CXBE but not CY-BG recipients: the same pattern induced by B6-wt T cells. This observation is consistent with previous findings that cytotoxic T lymphocyte (CTL) responses against CXBG and CXBE antigens did not correlate with GvH responses in these strains. In contrast with the typical pattern of donor T-cell expansion and contraction, T cells lacking perforin and FasH function exhibited extensive expansion postBMT. In summary, these findings support the notion that donor anti-host cytotoxicity by way of the two major pathways is not a prerequisite for induction of GvHD. In addition, the results suggest that this model will be useful to investigate the regulation of allogeneic donor T-cell expansion after major histocompatibility complex-matched allogeneic BMT.
引用
收藏
页码:804 / 812
页数:9
相关论文
共 24 条
  • [21] BONE-MARROW TRANSPLANTATION ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS IN MICE - EFFECT OF ELIMINATION OF T-CELLS FROM DONOR GRAFTS BY TREATMENT WITH MONOCLONAL THY-1.2 PLUS COMPLEMENT OR ANTIBODY ALONE
    VALLERA, DA
    SODERLING, CCB
    CARLSON, GJ
    KERSEY, JH
    TRANSPLANTATION, 1981, 31 (03) : 218 - 222
  • [22] DONOR TYPE NATURAL-KILLER-CELLS AFTER HAPLOIDENTICAL T-CELL-DEPLETED BONE-MARROW STEM-CELL TRANSPLANTATION IN A PATIENT WITH ADENOSINE DEAMINASE-DEFICIENT SEVERE COMBINED IMMUNODEFICIENCY
    GAINES, AD
    SCHIFF, SE
    BUCKLEY, RH
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 60 (02): : 299 - 304
  • [23] Recipient Myeloid-Derived Immunomodulatory Cells Induce PD-1 Ligand-Dependent Donor CD4+Foxp3+ Regulatory T Cell Proliferation and Donor-Recipient Immune Tolerance after Murine Nonmyeloablative Bone Marrow Transplantation
    van der Merwe, Marie
    Abdelsamed, Hossam A.
    Seth, Aman
    Ong, Taren
    Vogel, Peter
    Pillai, Asha B.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (11): : 5764 - 5776
  • [24] ESTABLISHMENT OF A NOVEL METHOD TO INDUCE TOLERANCE IN ADULT MICE ACROSS FULLY ALLOGENEIC (ENTIRE H-2 PLUS MULTIMINOR HISTOCOMPATIBILITY) ANTIGEN BARRIERS, USING SUPRALETHAL IRRADIATION FOLLOWED BY INJECTION OF SYNGENEIC BONE-MARROW CELLS PLUS (DONOR X RECIPIENT) F1 SPLEEN-CELLS
    TOMITA, Y
    HIMENO, K
    MAYUMI, H
    TOKUDA, N
    NOMOTO, K
    IMMUNOBIOLOGY, 1989, 179 (2-3) : 214 - 229